Repository logo
 
Publication

The Use of Recombinant Activated FVII (rFVIIa, Novoseven®) in the Treatment of Patients with Haemophilia and Inhibitors

2000Other Open access
Simple item page
dc.contributor.authorDiniz, MJ
dc.contributor.authorGalvão, M
dc.contributor.authorTavares, A
dc.contributor.authorVieira, A
dc.contributor.authorFalcão, MT
dc.contributor.authorCatarino, C
dc.contributor.authorCruz, C
dc.date.accessioned2011-11-30T10:37:26Z
dc.date.available2011-11-30T10:37:26Z
dc.date.issued2000
dc.identifier.citationIN: XXIV International Congress of the World Federation of Hemophilia, 2000, 16 a 21 Julho. Montreal, Canadá.por
dc.identifier.urihttp://hdl.handle.net/10400.17/520
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherServiço de Imunohemoterapia do Hospital de S. José e do Hospital de Sta. Mariapor
dc.subjectFactor VIIapor
dc.subjectHemofilia Apor
dc.subjectHemofilia Bpor
dc.subjectEstudos Retrospectivospor
dc.titleThe Use of Recombinant Activated FVII (rFVIIa, Novoseven®) in the Treatment of Patients with Haemophilia and Inhibitorspor
dc.typeother
dspace.entity.typePublication
oaire.citation.conferencePlaceMontreal, Canadápor
rcaap.rightsopenAccesspor
rcaap.typeotherpor

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Poster FVIIaR Canada 2000.pdf
Size:
74.97 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

IMU - Comunicações e Conferências